×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CATX – perspective therapeutics, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CATX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/17
07:00 am
catx
Perspective Therapeutics to Provide Business Highlights and Report First Quarter 2025 Financial Results
Medium
Report
Perspective Therapeutics to Provide Business Highlights and Report First Quarter 2025 Financial Results
4/11
07:00 am
catx
Perspective Therapeutics Announces First Patient Dosed with [212Pb]VMT01 Monotherapy at 1.5 mCi in a Phase 1/2a Study of MC1R-Positive Metastatic Melanoma
High
Report
Perspective Therapeutics Announces First Patient Dosed with [212Pb]VMT01 Monotherapy at 1.5 mCi in a Phase 1/2a Study of MC1R-Positive Metastatic Melanoma
4/7
10:05 am
catx
Perspective Therapeutics, Inc. (NYSE: CATX) had its price target lowered by analysts at Truist Financial Co. from $21.00 to $10.00. They now have a "buy" rating on the stock.
Medium
Report
Perspective Therapeutics, Inc. (NYSE: CATX) had its price target lowered by analysts at Truist Financial Co. from $21.00 to $10.00. They now have a "buy" rating on the stock.
3/31
08:56 am
catx
Perspective Therapeutics, Inc. (NYSE: CATX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Medium
Report
Perspective Therapeutics, Inc. (NYSE: CATX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
3/31
07:00 am
catx
Perspective Therapeutics to Participate in Upcoming April Investor Conferences
High
Report
Perspective Therapeutics to Participate in Upcoming April Investor Conferences
3/27
11:14 am
catx
Perspective Therapeutics, Inc. (NYSE: CATX) had its price target lowered by analysts at Royal Bank of Canada from $16.00 to $15.00. They now have an "outperform" rating on the stock.
Low
Report
Perspective Therapeutics, Inc. (NYSE: CATX) had its price target lowered by analysts at Royal Bank of Canada from $16.00 to $15.00. They now have an "outperform" rating on the stock.
3/26
08:20 pm
catx
Perspective Therapeutics, Inc. (NYSE: CATX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
Low
Report
Perspective Therapeutics, Inc. (NYSE: CATX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
3/26
04:10 pm
catx
Perspective Therapeutics Provides Recent Business Highlights and Reports Full Year 2024 Results
Low
Report
Perspective Therapeutics Provides Recent Business Highlights and Reports Full Year 2024 Results
Date
Time
Symbol
Company Name
Action
%Chg
11/12/2024
04:05 pm
CATX
perspective therapeutics, inc.
IN-LINE
Report
-7.0%
perspective therapeutics, inc.
8/12/2024
04:05 pm
CATX
perspective therapeutics, inc.
BEAT
Report
5.7%
perspective therapeutics, inc.
8/12/2024
04:05 pm
CATX
perspective therapeutics, inc.
BEAT
Report
5.7%
perspective therapeutics, inc.
8/12/2024
04:05 pm
CATX
perspective therapeutics, inc.
BEAT
Report
15.7%
perspective therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/16
04:31 pm
catx
Form DEFA14A Perspective Therapeutics
Low
Report
Form DEFA14A Perspective Therapeutics
4/16
04:31 pm
catx
Form DEF 14A Perspective Therapeutics For: Dec 31
Low
Report
Form DEF 14A Perspective Therapeutics For: Dec 31
4/11
07:08 am
catx
Form 8-K Perspective Therapeutics For: Apr 11
Medium
Report
Form 8-K Perspective Therapeutics For: Apr 11
4/9
06:01 am
catx
Form EFFECT Perspective Therapeutics
High
Report
Form EFFECT Perspective Therapeutics
4/4
05:15 pm
catx
Form POS AM Perspective Therapeutics
Neutral
Report
Form POS AM Perspective Therapeutics
4/1
06:45 pm
catx
Form 4 Perspective Therapeutics For: Mar 28 Filed by: Spoor Johan M.
Neutral
Report
Form 4 Perspective Therapeutics For: Mar 28 Filed by: Spoor Johan M.
4/1
05:05 pm
catx
Form 4 Perspective Therapeutics For: Mar 28 Filed by: Williamson Robert F III
Medium
Report
Form 4 Perspective Therapeutics For: Mar 28 Filed by: Williamson Robert F III
4/1
05:04 pm
catx
Form 4 Perspective Therapeutics For: Mar 28 Filed by: Graham Juan
Medium
Report
Form 4 Perspective Therapeutics For: Mar 28 Filed by: Graham Juan
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: